Search

Showing "11155" results for ""

Financial worries predict poor adherence to anti-HIV therapy in US patients

Hypersensitivity reaction in patient taking Truvada with similar symptoms to abacavir allergy

Fosamprenavir: US approves once-daily dose with less ritonavir boosting

Atripla takes a key step towards European approval

Liver fibrosis often progresses rapidly in HIV/HCV co-infected; elevated AST levels best predictor

PEPFAR money being used to 'promote homophobia', charges human rights group

HIV testing in the US: those at highest risk also most likely to put off testing

Detecting primary HIV infection in Africa without viral load test is possible

Pregnancy rather than HIV affects blood levels of antimalarial drug

Swiss find no increase in transmitted resistance over past decade

Rectal inflammation study establishes normal values, confirms efficacy of potent anti-HIV therapy

Paradox: people with moderate viral load more likely to pass on HIV

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines

Lower weight explains why HIV-positive patients have a risk of lower bone mineral density

Bevirimat 300mg oral solution dose does well in study

Women who don't have enough to eat taking more sexual risks in Africa

Boosted saquinavir as good as Kaletra, Gemini study shows

Girls aged 12 and 13 to get HPV vaccination in England, two year catch-up to vaccinate girls aged up to 18

Receive the latest HIV research and conference news

Showing "11155" results for ""

Financial worries predict poor adherence to anti-HIV therapy in US patients

Hypersensitivity reaction in patient taking Truvada with similar symptoms to abacavir allergy

Fosamprenavir: US approves once-daily dose with less ritonavir boosting

Atripla takes a key step towards European approval

Liver fibrosis often progresses rapidly in HIV/HCV co-infected; elevated AST levels best predictor

PEPFAR money being used to 'promote homophobia', charges human rights group

HIV testing in the US: those at highest risk also most likely to put off testing

Detecting primary HIV infection in Africa without viral load test is possible

Pregnancy rather than HIV affects blood levels of antimalarial drug

Swiss find no increase in transmitted resistance over past decade

Rectal inflammation study establishes normal values, confirms efficacy of potent anti-HIV therapy

Paradox: people with moderate viral load more likely to pass on HIV

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines

Lower weight explains why HIV-positive patients have a risk of lower bone mineral density

Bevirimat 300mg oral solution dose does well in study

Women who don't have enough to eat taking more sexual risks in Africa

Boosted saquinavir as good as Kaletra, Gemini study shows

Girls aged 12 and 13 to get HPV vaccination in England, two year catch-up to vaccinate girls aged up to 18

Receive the latest HIV research and conference news